Lung Fung Group Holdings Limited (2290.HK) Stock Competitors & Peer Comparison
See (2290.HK) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Distribution Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 2290.HK | HK$3.74 | +4.76% | 1.9B | 0.02 | HK$170.43 | N/A |
| 2607.HK | HK$11.98 | -0.75% | 70B | 6.29 | HK$1.92 | +4.45% |
| 1099.HK | HK$17.47 | -0.57% | 55B | 6.99 | HK$2.52 | +4.48% |
| 2192.HK | HK$7.46 | -1.71% | 5.6B | 15.20 | HK$0.50 | +3.85% |
| 2656.HK | HK$9.78 | +4.38% | 3.4B | -34.75 | -HK$0.28 | N/A |
| 2427.HK | HK$2.27 | +3.18% | 2.1B | -72.67 | -HK$0.03 | N/A |
| 1931.HK | HK$0.64 | +1.59% | 1B | 3.27 | HK$0.20 | N/A |
| 2289.HK | HK$6.90 | -5.48% | 788.4M | 13.84 | HK$0.53 | +4.71% |
| 9955.HK | HK$0.51 | -3.77% | 335.8M | -0.95 | -HK$0.55 | N/A |
| 1298.HK | HK$1.20 | +0.00% | 330.5M | 87.91 | HK$0.01 | N/A |
Stock Comparison
2290.HK vs 2607.HK Comparison July 2026
2290.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2290.HK stands at 1.9B. In comparison, 2607.HK has a market cap of 70B. Regarding current trading prices, 2290.HK is priced at HK$3.74, while 2607.HK trades at HK$11.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2290.HK currently has a P/E ratio of 0.02, whereas 2607.HK's P/E ratio is 6.29. In terms of profitability, 2290.HK's ROE is N/A, compared to 2607.HK's ROE of +0.08%. Regarding short-term risk, 2290.HK is more volatile compared to 2607.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2290.HK.Check 2607.HK's competition here
2290.HK vs 1099.HK Comparison July 2026
2290.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2290.HK stands at 1.9B. In comparison, 1099.HK has a market cap of 55B. Regarding current trading prices, 2290.HK is priced at HK$3.74, while 1099.HK trades at HK$17.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2290.HK currently has a P/E ratio of 0.02, whereas 1099.HK's P/E ratio is 6.99. In terms of profitability, 2290.HK's ROE is N/A, compared to 1099.HK's ROE of +0.09%. Regarding short-term risk, 2290.HK is more volatile compared to 1099.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2290.HK.Check 1099.HK's competition here
2290.HK vs 2192.HK Comparison July 2026
2290.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2290.HK stands at 1.9B. In comparison, 2192.HK has a market cap of 5.6B. Regarding current trading prices, 2290.HK is priced at HK$3.74, while 2192.HK trades at HK$7.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2290.HK currently has a P/E ratio of 0.02, whereas 2192.HK's P/E ratio is 15.20. In terms of profitability, 2290.HK's ROE is N/A, compared to 2192.HK's ROE of +0.07%. Regarding short-term risk, 2290.HK is more volatile compared to 2192.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2290.HK.Check 2192.HK's competition here
2290.HK vs 2656.HK Comparison July 2026
2290.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2290.HK stands at 1.9B. In comparison, 2656.HK has a market cap of 3.4B. Regarding current trading prices, 2290.HK is priced at HK$3.74, while 2656.HK trades at HK$9.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2290.HK currently has a P/E ratio of 0.02, whereas 2656.HK's P/E ratio is -34.75. In terms of profitability, 2290.HK's ROE is N/A, compared to 2656.HK's ROE of N/A. Regarding short-term risk, 2290.HK is more volatile compared to 2656.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2290.HK.Check 2656.HK's competition here
2290.HK vs 2427.HK Comparison July 2026
2290.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2290.HK stands at 1.9B. In comparison, 2427.HK has a market cap of 2.1B. Regarding current trading prices, 2290.HK is priced at HK$3.74, while 2427.HK trades at HK$2.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2290.HK currently has a P/E ratio of 0.02, whereas 2427.HK's P/E ratio is -72.67. In terms of profitability, 2290.HK's ROE is N/A, compared to 2427.HK's ROE of N/A. Regarding short-term risk, 2290.HK is less volatile compared to 2427.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2290.HK.Check 2427.HK's competition here
2290.HK vs 1931.HK Comparison July 2026
2290.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2290.HK stands at 1.9B. In comparison, 1931.HK has a market cap of 1B. Regarding current trading prices, 2290.HK is priced at HK$3.74, while 1931.HK trades at HK$0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2290.HK currently has a P/E ratio of 0.02, whereas 1931.HK's P/E ratio is 3.27. In terms of profitability, 2290.HK's ROE is N/A, compared to 1931.HK's ROE of +0.01%. Regarding short-term risk, 2290.HK is more volatile compared to 1931.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2290.HK.Check 1931.HK's competition here
2290.HK vs 2289.HK Comparison July 2026
2290.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2290.HK stands at 1.9B. In comparison, 2289.HK has a market cap of 788.4M. Regarding current trading prices, 2290.HK is priced at HK$3.74, while 2289.HK trades at HK$6.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2290.HK currently has a P/E ratio of 0.02, whereas 2289.HK's P/E ratio is 13.84. In terms of profitability, 2290.HK's ROE is N/A, compared to 2289.HK's ROE of +0.08%. Regarding short-term risk, 2290.HK is more volatile compared to 2289.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2290.HK.Check 2289.HK's competition here
2290.HK vs 9955.HK Comparison July 2026
2290.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2290.HK stands at 1.9B. In comparison, 9955.HK has a market cap of 335.8M. Regarding current trading prices, 2290.HK is priced at HK$3.74, while 9955.HK trades at HK$0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2290.HK currently has a P/E ratio of 0.02, whereas 9955.HK's P/E ratio is -0.95. In terms of profitability, 2290.HK's ROE is N/A, compared to 9955.HK's ROE of -1.22%. Regarding short-term risk, 2290.HK is more volatile compared to 9955.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2290.HK.Check 9955.HK's competition here
2290.HK vs 1298.HK Comparison July 2026
2290.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2290.HK stands at 1.9B. In comparison, 1298.HK has a market cap of 330.5M. Regarding current trading prices, 2290.HK is priced at HK$3.74, while 1298.HK trades at HK$1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2290.HK currently has a P/E ratio of 0.02, whereas 1298.HK's P/E ratio is 87.91. In terms of profitability, 2290.HK's ROE is N/A, compared to 1298.HK's ROE of -0.01%. Regarding short-term risk, 2290.HK is more volatile compared to 1298.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2290.HK.Check 1298.HK's competition here
2290.HK vs 0557.HK Comparison July 2026
2290.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2290.HK stands at 1.9B. In comparison, 0557.HK has a market cap of 239.4M. Regarding current trading prices, 2290.HK is priced at HK$3.74, while 0557.HK trades at HK$0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2290.HK currently has a P/E ratio of 0.02, whereas 0557.HK's P/E ratio is -11.17. In terms of profitability, 2290.HK's ROE is N/A, compared to 0557.HK's ROE of -0.19%. Regarding short-term risk, 2290.HK is less volatile compared to 0557.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2290.HK.Check 0557.HK's competition here
2290.HK vs 0673.HK Comparison July 2026
2290.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2290.HK stands at 1.9B. In comparison, 0673.HK has a market cap of 184.8M. Regarding current trading prices, 2290.HK is priced at HK$3.74, while 0673.HK trades at HK$0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2290.HK currently has a P/E ratio of 0.02, whereas 0673.HK's P/E ratio is -4.30. In terms of profitability, 2290.HK's ROE is N/A, compared to 0673.HK's ROE of -2.73%. Regarding short-term risk, 2290.HK is less volatile compared to 0673.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2290.HK.Check 0673.HK's competition here
2290.HK vs 0718.HK Comparison July 2026
2290.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2290.HK stands at 1.9B. In comparison, 0718.HK has a market cap of 178.5M. Regarding current trading prices, 2290.HK is priced at HK$3.74, while 0718.HK trades at HK$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2290.HK currently has a P/E ratio of 0.02, whereas 0718.HK's P/E ratio is -0.25. In terms of profitability, 2290.HK's ROE is N/A, compared to 0718.HK's ROE of +0.22%. Regarding short-term risk, 2290.HK is more volatile compared to 0718.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2290.HK.Check 0718.HK's competition here
2290.HK vs 2393.HK Comparison July 2026
2290.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2290.HK stands at 1.9B. In comparison, 2393.HK has a market cap of 130.6M. Regarding current trading prices, 2290.HK is priced at HK$3.74, while 2393.HK trades at HK$0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2290.HK currently has a P/E ratio of 0.02, whereas 2393.HK's P/E ratio is -0.69. In terms of profitability, 2290.HK's ROE is N/A, compared to 2393.HK's ROE of -0.18%. Regarding short-term risk, 2290.HK is more volatile compared to 2393.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2290.HK.Check 2393.HK's competition here
2290.HK vs 8372.HK Comparison July 2026
2290.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2290.HK stands at 1.9B. In comparison, 8372.HK has a market cap of 106.4M. Regarding current trading prices, 2290.HK is priced at HK$3.74, while 8372.HK trades at HK$0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2290.HK currently has a P/E ratio of 0.02, whereas 8372.HK's P/E ratio is 9.03. In terms of profitability, 2290.HK's ROE is N/A, compared to 8372.HK's ROE of +0.09%. Regarding short-term risk, 2290.HK is less volatile compared to 8372.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2290.HK.Check 8372.HK's competition here
2290.HK vs 0401.HK Comparison July 2026
2290.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2290.HK stands at 1.9B. In comparison, 0401.HK has a market cap of 66.7M. Regarding current trading prices, 2290.HK is priced at HK$3.74, while 0401.HK trades at HK$0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2290.HK currently has a P/E ratio of 0.02, whereas 0401.HK's P/E ratio is -1.87. In terms of profitability, 2290.HK's ROE is N/A, compared to 0401.HK's ROE of -0.19%. Regarding short-term risk, 2290.HK is more volatile compared to 0401.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2290.HK.Check 0401.HK's competition here